3 challenges to watch in global health in 2023 As the third year of the Covid pandemic ends and we look to 2023, what can be spotted on the horizon? Helen Branswell STAT

...

As the third year of the Covid pandemic ends and 2023 begins, what can be spotted on the horizon? We already know about a bunch of things that are going to jostle for our attention; rest assured others we’re not anticipating will materialize as well.

 ...three issues we can see right now.

China COVID data shows no new variant, WHO says, easing some global fears No new coronavirus variant has been found in China, data released by the World Health Organization showed on Wednesday, easing some concerns about an outbreak that has spread rapidly there since Beijing abruptly reversed its "zero COVID" policy. Alessandro Diviggiano,Bernard Orr Reuters

...

Covid misinformation spikes in wake of Damar Hamlin's on-field collapse The baseless tweets began to circulate within minutes of Buffalo Bills safety Damar Hamlin's stunning collapse on the field during "Monday Night Football." Anti-vaxxers and right-wing provocateurs sought to link the injury that left Hamlin in critical condition and the coronavirus vaccine, without any evidence. Their claims built on years of coronavirus vaccine misinformation that has been seeded across social media.Subscribe to The Post Most newsletter for the most important and interesting sto YahooNews

...

'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge The problem is a growing headache for Beijing as it tries to persuade more people to get vaccinated in the face of a spike in infections and the prospect of more than 1.5 million deaths after the lifting of strict anti-COVID measures. David Kirton Reuters

...

COVID-19 Virus Found in the Brain: Autopsies Reveal Startling New Information An analysis of tissue samples from the autopsies of 44 people who died with COVID-19 shows that SAR-CoV-2 virus spread throughout the body—including into the brain—and that it lingered for almost 8 months. The study was published on December 14 in the journal Nature. Scientists from the National Mike O'Neill SciTechDaily

...

COVID booster prompts good immune response, except after recent infection CIDRAP

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US | CNN The CDC estimates that XBB.1.5 has more than doubled its share of the Covid-19 pie each week for the last four, rising from about 4% to 41% of new infections over the month of December. Brenda Goodman CNN

...

COVID variant XBB.1.5 now accounts for 40 percent of cases in the US: CDC The omicron subvariant XBB.1.5 has rapidly spread to become the dominant COVID-19 mutation in the U.S., now accounting for 40.5 percent of all cases. The XBB.1.5 omicron subvariant as of this week … jchoi The Hill

...

Lack of info on China's COVID-19 surge stirs global concern BEIJING (AP) — Moves by several countries to mandate COVID-19 tests for passengers arriving from China reflect global concern that new variants could emerge in its ongoing explosive outbreak — and that the government may not inform the rest of the world quickly enough. AP NEWS

...

A promising new Covid pill shows key advantages over Paxlovid in trial A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and it appeared to cause fewer side effects. NBC News

...

"You have a medication that looks to be just as good as Paxlovid, but less cumbersome," said Dr. Panagis Galiatsatos, an assistant professor of medicine at Johns Hopkins Medicine in Baltimore.

...

COVID Smell Loss: 'Retraining' Mostly Flops in Trial Some patients did recover olfactory function with two-prong therapy, however Kate Kneisel medpagetoday

...

Bimodal olfactory training with visual cues and the use of patient-preferred scents did not produce a clinically meaningful improvement in sense of smell among individuals with COVID-19–related olfactory loss, a 275-patient randomized trial showed.

...

Opinion | COVID's Lasting Consequences for Kids Allergist Zachary Rubin, MD, details the post-COVID symptoms presenting at his clinic Emily Hutto medpagetoday

...

In this video, MedPage Today editor-in-chief Jeremy Faust, MD, sits down with allergist and immunologist Zachary Rubin, MD, of Oak Brook Allergists in Illinois, to discuss the lasting effects of COVID-19 on pediatric health.

...